Early research (Phase 1)Study completedNCT02138929What this trial is testingLDE225 + Everolimus in Advanced Gastroesophageal AdenocarcinomaWho this might be right forEsophageal Cancer M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT01130337What this trial is testingCapecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric CancerWho this might be right forGastric Cancer Hoffmann-La Roche 36
Testing effectiveness (Phase 2)UnknownNCT04061928What this trial is testingToripalimab With Preoperative Chemoradiotherapy for LA-EGJWho this might be right forPD-1ChemoradiotherapyGastroesophageal Junction Cancer Peking University 45
Testing effectiveness (Phase 2)Ended earlyNCT02485834What this trial is testingFDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionGastric AdenocarcinomaGastric Cancer Alliance for Clinical Trials in Oncology 5
Early research (Phase 1)Study completedNCT01042782What this trial is testingPhase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric JunctionWho this might be right forAdvanced Gastric CancerAdvanced Cancer of the Esophagogastric Junction Krankenhaus Nordwest 16
Early research (Phase 1)Looking for participantsNCT06266299What this trial is testingKK2269 in Adult Participants With Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorGastric Adenocarcinoma+3 more Kyowa Kirin Co., Ltd. 101
Testing effectiveness (Phase 2)Study completedNCT01231399What this trial is testingEverolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal CancerWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+6 more City of Hope Medical Center 6
Early research (Phase 1)Not Yet RecruitingNCT07358884What this trial is testingFirst in Human Study of QLS5316 in Solid TumorsWho this might be right forSolid TumorsColorectal CancerGastric Cancer or Gastroesophageal Junction Adenocarcinoma+2 more Qilu Pharmaceutical Co., Ltd. 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT05128487What this trial is testingNDI 1150-101 in Patients With Solid TumorsWho this might be right forSolid TumorRenal Cell Carcinoma (Kidney Cancer)Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+1 more Nimbus Saturn, Inc. 106
Testing effectiveness (Phase 2)Study completedNCT00470184What this trial is testingOxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal CancerWho this might be right forEsophageal Cancer Roswell Park Cancer Institute 41
Large-scale testing (Phase 3)Looking for participantsNCT06949033What this trial is testingNeoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])Neoadjuvant TherapyAdjuvant Chemotherapy+3 more Zuoyi Jiao 668
Large-scale testing (Phase 3)Study completedNCT01404156What this trial is testingPreoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ AdenocarcinomaWho this might be right forEsophageal CancerAdenocarcinoma, EsophagealAdenocarcinoma, Gastroesophageal Junction Dr. Gordon Buduhan 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT03979131What this trial is testingPhase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC)Who this might be right forGastroesophageal Junction AdenocarcinomaStomach Neoplasms Vall d'Hebron Institute of Oncology 40
Not applicableLooking for participantsNCT06902545What this trial is testingObserve the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.Who this might be right forLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more Astellas Pharma Korea, Inc.
Early research (Phase 1)Study completedNCT01576666What this trial is testingPhase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsWho this might be right forDose EscalationSafetyPreliminary Efficacy+9 more Novartis Pharmaceuticals 120
Large-scale testing (Phase 3)Looking for participantsNCT04997837What this trial is testingStudy of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ AdenocarcinomaWho this might be right forGastric Cancer Fudan University 433
Testing effectiveness (Phase 2)Ended earlyNCT01830270What this trial is testingPreoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric CancerWho this might be right forStomach NeoplasmsOesophageal Junction CancerLower Oesophagus Cancer Centre Hospitalier Universitaire de Besancon 30
Testing effectiveness (Phase 2)Study completedNCT00054457What this trial is testingDocetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal JunctionWho this might be right forEsophageal CancerGastric Cancer Alliance for Clinical Trials in Oncology 46
Testing effectiveness (Phase 2)Ended earlyNCT00130936What this trial is testingStudy of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic CorrelatesWho this might be right forGastric CancerEsophageal CancerTumors AHS Cancer Control Alberta 50
Testing effectiveness (Phase 2)Looking for participantsNCT05563766What this trial is testingA Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal CancerWho this might be right forEsophageal AdenocarcinomaEsophageal Squamous Cell CarcinomaGastroesophageal Junction Carcinoma VA Office of Research and Development 78